Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
UCB |
---|---|
Information provided by: | UCB |
ClinicalTrials.gov Identifier: | NCT00160680 |
Comparison of clinical efficacy and safety of levocetirizine in PER continuous versus on demand, measured by evolution of individual symptom scores during 6 months.
Condition | Intervention | Phase |
---|---|---|
Rhinitis, Allergic, Perennial |
Drug: Levocetirizine |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Parallel Assignment |
Official Title: | A Pilot, Open, Monocenter Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 Months |
Estimated Enrollment: | 100 |
Study Start Date: | March 2005 |
Study Completion Date: | June 2006 |
Primary Completion Date: | June 2006 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | A00392, EudraCT 2004-003858-26, ATAREAL |
Study First Received: | September 8, 2005 |
Last Updated: | March 6, 2008 |
ClinicalTrials.gov Identifier: | NCT00160680 |
Health Authority: | Italy: The Italian Medicines Agency |
Persistent Allergic Rhinitis, HDM, Parietaria, sneezing, rhinorrhea, ocular pruritus, Rhinasthma, inflammatory cells, ICAM-1, ATAREAL, Xyzal, Levocetirizine |
Pruritus Hypersensitivity Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases Rhinitis, Allergic, Perennial |
Levocetirizine Hypersensitivity, Immediate Histamine phosphate Rhinitis Histamine Respiratory Hypersensitivity |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Histamine Antagonists Immune System Diseases Physiological Effects of Drugs |
Histamine Agents Histamine H1 Antagonists Histamine H1 Antagonists, Non-Sedating Pharmacologic Actions Nose Diseases |